Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Clinical Neurology and Neurosurgery|February 21, 2024
COVID-19 vaccine response in Neuromyelitis Optica Spectrum DisorderCavid Baba, Ergi Kaya, Sinem Ozcelik, et al.
Multiple Sclerosis and Related Disorders|February 16, 2021
Validity and reliability of "Cognitive Reserve Index Questionnaire" for the Turkish PopulationSerkan Ozakbas, Pinar Yigit, Zeynep Akyuz, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2010
A case of fever of unknown origin: co-existence of Kikuchi-Fujimoto disease and acute disseminated encephalomyelitis (ADEM)Vildan Avkan-Oguz, Nur Yapar, Serkan Ozakbas, et al.
Multiple Sclerosis and Related Disorders|October 4, 2024
Manifestations of walking fatigability in people with multiple sclerosis based on gait quality and distance walked during the six minutes walking testFelipe Balistieri Santinelli, Zuhal Abasıyanık, Cintia Ramari, et al.
Multiple Sclerosis and Related Disorders|September 7, 2023
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatmentSedat Sen, Asli Tuncer, Murat Terzi, et al.
CNS Drugs|September 6, 2024
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry StudyDaniel Kreiter, Tomas Kalincik, Raymond Hupperts, et al.
Multiple Sclerosis and Related Disorders|April 2, 2018
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trialSerkan Ozakbas, Recai Turkoglu, Yusuf Tamam, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Multiple Sclerosis and Related Disorders|February 6, 2023
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activityTim Spelman, Dana Horakova, Serkan Ozakbas, et al.
Neuroimage. Clinical|September 1, 2021
Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase studyMichael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, et al.
Pageof 15